135 related articles for article (PubMed ID: 20418268)
1. Protective effects of aliskiren in doxorubicin-induced acute cardiomyopathy in rats.
Rashikh A; Abul Kalam Najmi ; Akhtar M; Mahmood D; Pillai KK; Ahmad SJ
Hum Exp Toxicol; 2011 Feb; 30(2):102-9. PubMed ID: 20418268
[TBL] [Abstract][Full Text] [Related]
2. Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy.
Rashikh A; Ahmad SJ; Pillai KK; Kohli K; Najmi AK
Biomed Pharmacother; 2012 Mar; 66(2):138-43. PubMed ID: 22386366
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of a direct renin inhibitor in acute murine model of cardiotoxicity and nephrotoxicity.
Rashikh A; Pillai KK; Najmi AK
Fundam Clin Pharmacol; 2014 Oct; 28(5):489-500. PubMed ID: 24117488
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury.
Rashikh A; Pillai KK; Ahmad SJ; Akhtar M; Najmi AK
J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):14-22. PubMed ID: 23060472
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
Fadillioğlu E; Erdoğan H; Söğüt S; Kuku I
J Appl Toxicol; 2003; 23(1):71-4. PubMed ID: 12518339
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
[TBL] [Abstract][Full Text] [Related]
7. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats.
Iqbal M; Dubey K; Anwer T; Ashish A; Pillai KK
Pharmacol Rep; 2008; 60(3):382-90. PubMed ID: 18622063
[TBL] [Abstract][Full Text] [Related]
9. Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress.
Andreadou I; Sigala F; Iliodromitis EK; Papaefthimiou M; Sigalas C; Aligiannis N; Savvari P; Gorgoulis V; Papalabros E; Kremastinos DT
J Mol Cell Cardiol; 2007 Mar; 42(3):549-58. PubMed ID: 17223128
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of 'Khamira Abresham Hakim Arshad Wala', a unani formulation against doxorubicin-induced cardiotoxicity and nephrotoxicity.
Nazmi AS; Ahmad SJ; Rashikh A; Akhtar M; Pillai KK; Najmi AK
Toxicol Mech Methods; 2011 Jan; 21(1):41-7. PubMed ID: 21067281
[TBL] [Abstract][Full Text] [Related]
12. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
El-Shitany NA; El-Haggar S; El-desoky K
Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats.
Koti BC; Vishwanathswamy AH; Wagawade J; Thippeswamy AH
Indian J Exp Biol; 2009 Jan; 47(1):41-6. PubMed ID: 19317350
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
Tesoriere L; Ciaccio M; Valenza M; Bongiorno A; Maresi E; Albiero R; Livrea MA
J Pharmacol Exp Ther; 1994 Apr; 269(1):430-6. PubMed ID: 8169849
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of pioglitazone against cardiovascular injury are enhanced by combination with aliskiren in a rat model of diabetic nephropathy.
Elrashidy RA; Asker ME; Mohamed HE
J Pharm Pharmacol; 2012 Jun; 64(6):862-71. PubMed ID: 22571265
[TBL] [Abstract][Full Text] [Related]
17. The Role of RAAS Inhibition by Aliskiren on Paracetamol-Induced Hepatotoxicity Model in Rats.
Karcioglu SS; Palabiyik SS; Bayir Y; Karakus E; Mercantepe T; Halici Z; Albayrak A
J Cell Biochem; 2016 Mar; 117(3):638-46. PubMed ID: 26280784
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
19. Yogurt Containing the Probacteria Lactobacillus acidophilus Combined with Natural Antioxidants Mitigates Doxorubicin-Induced Cardiomyopathy in Rats.
Abu-Elsaad NM; Abd Elhameed AG; El-Karef A; Ibrahim TM
J Med Food; 2015 Sep; 18(9):950-9. PubMed ID: 25590792
[TBL] [Abstract][Full Text] [Related]
20. Biochemical study on the protective potential of Nardostachys jatamansi extract on lipid profile and lipid metabolizing enzymes in doxorubicin intoxicated rats.
Subashini R; Ragavendran B; Gnanapragasam A; Yogeeta SK; Devaki T
Pharmazie; 2007 May; 62(5):382-7. PubMed ID: 17557749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
